Despite global uncertainty, we remain committed to uniting this dedicated community and streamlining progression of RAS targeted therapeutics – and so we are excited to transform the 2nd RAS Targeted Drug Development Summit into a fully digital event.

Explore novel discoveries, identify rational anti-RAS combination strategies & accelerate the translation of next generation mutant-targeted RAS therapies into human clinical trials

As the first KRAS inhibitors reach the clinic and show promising opportunities to address unmet clinical need, the 2nd RAS Targeted Drug Development Summit 2020 returns to drive forward the clinical translation of first-generation anti-RAS therapies

This two-track meeting will be your comprehensive and definitive platform, dedicated to virtually uniting the largest community of RAS experts from large pharma, innovative biotech and research institutes to capitalize on the emerging therapeutic opportunities to finally bring an end to RAS driven cancers